TLT: Are We In A 'Soft Landing' Again?
TLT experienced a 6% pullback, approaching oversold levels, driven by stronger job data that priced in a "soft landing" scenario and created a 'Goldilocks' environment for equities. Investors should remain cautious as consumer credit continues to worsen, given that positive economic data can fluctuate, and historical recessions often follow exuberant stock markets. The FY2025 S&P 500 earnings consensus remains lofty, indicating 15% YoY growth and an acceleration from 11% YoY in FY2024, despite the current stage of economic slowdown.
Stock Market ETFs Trading Update: Watch Long Bonds (TLT)
I'd say “if the Economic Modern Family could speak..." However, they can, and they do. And what are they saying after a week of China flying, metals rallying, yields and dollar flattening, natural gas bottoming and oil prices dropping? Not too much….YET!
TLT: This Is Why Bonds Dropped After The 50bps Cut
The Fed's 50bps cut was a surprise to some, and so was the reaction in bonds. TLT is down around -3.5% from the September high when many thought it would rally if the Fed cut 50bps.
Treasury Bonds Update: What's Next For TLT?
Instead of falling after the Fed lowered rates, the 10-year and 20+ year yields have risen. This seems incongruous given the dovish Fed talk.
The Bond Yields Could Rise And Sink The Economy - The Fed Is Playing With Fire
Long-term bond yields have been rising since the Fed cut, led by rising inflation expectations. If the market senses that the Fed is allowing higher inflation to protect full employment, the yields could spike higher as inflation expectations de-anchor.
TLT: What Is There To Like When The USA Is $35 Trillion In Debt?
The US national debt is rapidly increasing, exposing long-dated government bonds to significant inflation risk, making iShares 20+ Year Treasury Bond ETF very risky. Rate cuts by the Fed mostly affect short-term rates, while long-term yields are driven by inflation expectations, which are rising. The Fed is increasingly the primary buyer of long-dated US debt, as organic demand dwindles, pushing long-term yields higher.
Treasury Bonds ETF (TLT): Bullish Elliott wave Opportunity on All Time Frames
The current environment for treasury bonds remains favorable for upward trades in the near term, with the biggest consideration being the time frame that an individual trader is working in. We expect to see upward moves lasting a few days and others lasting several weeks.
TLT Broke Out And Should Continue Higher (Technical Analysis)
TLT just broke out, reaching a higher high for 2024, driven by anticipated rate cuts and lower inflation, and should be expected to trend higher. Long-term Treasuries offer steady income, high credit ratings, and act as a hedge against equity downturns, especially amid global economic uncertainty. TLT's chart shows a rounded bottoming pattern, indicating strong potential for further gains, particularly with forthcoming rate cuts and potential market weakness.
TLT: Positioned For Upside During Fed Rate Cuts And Recession Risks
Historical Fed rate pivots often precede recessions, highlighting deeper economic issues and potential downturns following interest rate cuts. Sharp declines in insider buying and job openings, coupled with rising consumer credit card delinquencies, signal significant economic stress and potential recession risks.
Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus
Theralase® Technologies Inc. is currently seeking partnerships / licensing opportunities in the commercial development of this latest discovery TORONTO, ON / ACCESSWIRE / September 3, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it's lead drug formulation, Ruvidar TM , has been demonstrated preclinically to be more effective in the destruction of the Herpes Simplex Virus 1 ("HSV-1") than the currently approved standard of care drug, Acyclovir. Acyclovir is an antiviral drug used to slow the growth and spread of the HSV-1 virus in the body.
ETF of the week: TLT waits for the Jackson Hole Symposium
The iShares 20+ Year Treasury Bond (TLT) ETF has crawled back in the past few months as concerns about the American economy have risen. The TLT ETF fund jumped to a high of $100 earlier this month, its highest point since May 2021.
TLT: Sahm Rule Triggered, Raising Recession Risk (Rating Upgrade)
TLT recently experienced a strong rally due to disappointing economic data and slower inflation, improving its negative correlation with the equity market. CPI YoY dropped below 3% for the first time since 2021, increasing expectations for Fed rate cuts and indicating that inflation is not capping TLT's upside potential. With the recent unemployment rate at 4.3% and the historically reliable Sahm Rule triggering a recession signal, the economy faces growing risks amid a still inverted yield curve.
